Tuberculosis: Challenges and Solutions for the 21st Century  by Swaminathan, S.
36 17th International Congress on Infectious Diseases / International Journal of Infectious Diseases 45S (2016) 1–477
Type: Oral Presentation
Final Abstract Number: 21.011
Session: Oral Presentations: HIV & Tuberculosis
Date: Friday, March 4, 2016
Time: 10:15-12:15
Room: G.05-06
Ps20: A novel correlate of inﬂammation and
infection in TB?
B.K. Sundararaj1,∗, G. D’Souza2, A. Jesuraj2, C.
Johnson3, W. Bonam3, L.E. Hannah4, S.
Swaminathan5, M. Thakkar6, A. Vyakarnam1
1 Indian Institute of Science, Bangalore, India
2 St. Johns Research Institute, Bangalore, India
3 Arogyavaram Medical Centre, Madanapalle, India
4 National Institute for Research in TB, Chennai, India
5 National Institute for Research in Tuberculosis
(ICMR), Chennai, India
6 National AIDS Research Institute, Pune, India
Background: The soluble factor ps20 encoded by the human
WFDC1 gene on Chromosome 16, is an ancient whey acidic protein
(WAP) family member, characterized by highly evolutionarily con-
served domain comprising eight cysteines that make 4 disulphide
bonds. WAPs are soluble innate immune mediators implicated
in homeostatic control of inﬂammation and broad anti-infective
activities. Previous studies in our laboratory highlighted a novel
function of ps20. We demonstrated ps20 expression in CD4-T cells,
which rendered these cells highly susceptible to HIV infection
through up-regulation of ICAM-1. Consistentwith this observation,
we showed that plasma ps20 levels positively correlated to CD4-
T cell count. We also demonstrated that ps20 levels at the CD4-T
cell level showed a strikingly inverse relationship with IFNg and
silencing of ps20 in CD4-T cell clones led to upregulation of IFNg.
This studywas designed to further examine the role of ps20 in IFNg
regulation in a chronic infection, such as TB, where IFNg levels are
known to be impaired.
Methods & Materials: (i) An in-house ps20-speciﬁc sandwich
ELISA was calibrated and used to conﬁrm ps20 levels in plasma
of 30 treatment naïve active TB, 15 TB treated (12 months post
treatment), 12 IGRA+ and 10 IGRA- subjects.
(ii) To further test if raised plasma ps20 in active TB correlated
with reduced IFNg expression, we measured the ps20 and IFNg
mRNA and protein levels in PBMC cultured activatedwith PHA/IL-2
in time-course assays.
(iii) Rapamycin, a known regulator of the mTOR pathway is
well established inhibitor of IFNg expression. We therefore used
this regulator to further determine if suppression of IFNg leads to
induction of ps20.
Results: (i) The ELISA data showed active TB subjects had a sig-
niﬁcantly higher (p =0.0356) plasma ps20 compared to IGRA+ and
IGRA- subjects.
(ii) PHA/IL-2 immunomodulation data conﬁrm active TB sub-
jects to have lower IFNg than IGRA+ and IGRA- subjects with
concomitantly higher ps20 expression.
(iii) Rapamycin Inhibition assay conﬁrms IFNg expression to be
signiﬁcantly reduced in thepresenceof Rapamycinwith a concomi-
tant marginal but consistent induction of ps20.
Conclusion: These studies highlight ps20 may be a novel regu-
lator of IFNg and provide novel insights on the possible role of ps20
in TB pathogenesis
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The healthy human antibiotic resistome: a
multi- body habitat analysis
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Abstract: The human body habitats are home to an array of
micro-organisms, and within these microbial ecosystems there is
an exchange of genetic material, including antibiotic resistance
genes. Recent metagenomic studies revealed that the human gut
microbiota is a reservoir of antibiotic resistant genes (the gut resis-
tome).However, little is knownabout thediversity andabundances
of antibiotic resistance genes in other body habitats and how that
compares to the gut resistome. By leveraging the most compre-
hensive human microbiome dataset of healthy adults generated by
the human microbiome project, we characterize the human micro-
biome resistome from four body habitats including gut (stool), oral,
anterior nares and vagina. The human resistomewas proﬁled using
ametagenomic shotgun sequencing alignment-based approach. By
determining the resistome size per individual we found resistance
genes distribute distinctly by body sites with certain body habitats
being abetter reservoirs thenothers. Furthermore,while resistance
classes were incoming among body habitats (e.g. tetracyclin), the
speciﬁc resistance genes per class were different (e.g. tetM in oral
vs tetQ in gut). The proﬁles of resistance genes (in the body sites
with universally present resistance genes) are more similar for the
same subjects over time than between subjects at the same time of
sampling. Finally, association analysis with sex, age and geography
